Basic Research
Copyright ©The Author(s) 2003. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Sep 15, 2003; 9(9): 2050-2053
Published online Sep 15, 2003. doi: 10.3748/wjg.v9.i9.2050
Kangxian ruangan keli inhibits hepatic stellate cell proliferation mediated by PDGF
Ling Yang, Chi-Zhi Zhang, Qing-Jing Zhu
Ling Yang, Department of Traditional Chinese Medicine, Union Hospital, Tongji Medical college, Huazhong University of Science and Technology, Wuhan 430022, Hubei Province, China
Chi-Zhi Zhang, Qing-Jing Zhu, Institute of Liver Diseases, Affiliated Hospital of Hubei College of Traditional Chinese Medicine, Wuhan 430061, Hubei Province, China
Author contributions: All authors contributed equally to the work.
Supported by the Natural Science Foundation of Hubei Province, No. 2000J042, and the Science Research Foundation of the Education Office of Hubei Province, No. 2000A06010
Correspondence to: Dr. Ling Yang, Department of Traditional Chinese Medicine, Union Hospital, Tongji Medical college, Huazhong University of Science and Technology, Wuhan 430022, Hubei Province, China. hepayang@163.com
Telephone: +86-27-85726395
Received: October 4, 2002
Revised: March 2, 2003
Accepted: March 12, 2003
Published online: September 15, 2003
Abstract

AIM: To investigate the effect of Kangxian ruangan keli (KXR) on hepatic stellate cell (HSC) proliferation mediated by platelet-derived growth factor (PDGF) and the underlying mechanism.

METHODS: In a serum-free culture system, HSCs were treated with a KXR preparation for 24 h, followed by stimulation with PDGF-BB for 24 h. Then the cells were incubated again in the medium containing KXR for 3 h stimulated with PDGF-BB for 5 minutes, and collected. The proliferation of HSC was examined using an MTT assay and flow cytometry. Tyrosine phosphorylation was detected with Western blotting and visualized by the enhenced chemiluminescent (ECL) method.

RESULTS: The OD values for the HSCs growing in the media without and with addition of PDGF were 0.17 ± 0.06 and 0.82 ± 0.05, respectively. The PDGF-induced increase was hindered remarkably by KXR preparation in a dose-dependent manner. The reaction values for the systems with 5 mg/mL, 2.5 mg/mL and 1.25 mg/mL of KXR were 0.28 ± 0.03, 0.37 ± 0.02 and 0.43 ± 0.04, respectively. Moreover, the percentages of S-phase cells in these KXR-containing culture systems were 10.95 ± 1.35, 32.76 ± 1.07 and 43.19 ± 1.09, respectively, all of which were significantly lower than that in the culture free of KXR (68.24 ± 2.72). In addition, the values for tyrosine-phosphorylated protein in HSCs treated with 5 mg/mL and 1.25 mg/mL of KXR were 0.1349 ± 0.0072 and 0.1658 ± 0.0025, respectively, which were smaller than that in the cells treated only with PDGF-BB (0.1813 ± 0.0117).

CONCLUSION: Within the dose range used in the present study, KXR preparation shows an inhibitory effect on HSC proliferation induced by PDGF. The mechanism of this process may involve interference with tyrosine phosphorylation mediated by PDGF.

Keywords: $[Keywords]